Cite Filings / DNLI / 0000315066-23-001353
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G/A

Amended Statement of Ownership

Denali Therapeutics Inc. · Filed 2023-02-09 · Acc 0000315066-23-001353

Documents 1

  • SC 13G/A Amended Statement of Ownership , filing.txt

Around this filing

  • 2023-02-13 4 President and CEO sold 28,433 shares at an average $29.28 ($832,515)
  • 2023-02-10 4 Chief Medical Officer sold 1,521 shares at $30.88 ($46,968)
  • 2023-02-10 4 COFO and Secretary sold 1,521 shares at $30.89 ($46,984)
  • 2023-02-10 4 Director sold 1,377 shares at $30.88 ($42,522)
  • 2023-02-09 SC 13G/A Amended Statement of Ownership
  • 2023-02-09 SC 13G/A Amended Statement of Ownership
  • 2023-02-01 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading filing.txt…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…